电邮这篇文章 The Hidden Dangers of Meftal: A Drug Safety Alert for a Frequently Used NSAID
- 作者: Paul P.1, Kamal R.2, Bhatia R.1
-
隶属关系:
- Department of Pharmaceutical Analysis, ISF College of Pharmacy
- Department of Quality Assurance, ISF College of Pharmacy
- 期: 卷 30, 编号 25 (2024)
- 页面: 1949-1951
- 栏目: Immunology, Inflammation & Allergy
- URL: https://snv63.ru/1381-6128/article/view/645834
- DOI: https://doi.org/10.2174/0113816128304156240606050525
- ID: 645834
如何引用文章
全文:
作者简介
Priyanka Paul
Department of Pharmaceutical Analysis, ISF College of Pharmacy
Email: info@benthamscience.net
Raj Kamal
Department of Quality Assurance, ISF College of Pharmacy
Email: info@benthamscience.net
Rohit Bhatia
Department of Pharmaceutical Analysis, ISF College of Pharmacy
编辑信件的主要联系方式.
Email: info@benthamscience.net
参考
- Central drugs standard control organization. Available from: https://cdsco.gov.in/opencms/opencms/en/Home
- Ahmad A, Patel I, Sanyal S, Balkrishnan R, Mohanta GP. A study on drug safety monitoring program in India. Indian J Pharm Sci 2014; 76(5): 379-86. PMID: 25425751
- Vaishnavi SG, Sachin H, Priyanka DY, Mohini AG, Ayesha NS, Madhav H. A review on banned drugs. AJPRD 2023; 11(6): 31-5. doi: 10.22270/ajprd.v11i6.1331
- Govt bans 14 fixed dose combination drugs including Nimesulide and Paracetamol, citing health risk; check full list here. Available from: https://www.livemint.com/news/govt-bans-14-fixed-dose-combination-drugs-including-paracetamol-citing-health-risk-full-list-here-11685840967218.html
- Meftal advisory: Why has government issued a safety alert against painkiller? Available from: https://www.indiatoday.in/health/story/why-has-the-government-issued-a-safety-alert-against-painkiller-meftal-2473604-2023-12-08
- Government advisory alerts users about Meftal's risks: Here's everything you need to know about it. Available from: https://economictimes.indiatimes.com/news/new-updates/government-advisory-alerts-users-about-meftals-risks-heres-everything-you-need-to-know-about-it/articleshow/105857731.cms
- Weiss D, Kinaciyan T. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by mefenamic acid. JAAD Case Rep 2019; 5(1): 89-90. doi: 10.1016/j.jdcr.2018.10.015 PMID: 30581942
- Doğan NÖ, Çaylak ST, Yılmaz S. Central nervous system toxicity due to mefenamic acid. Am J Emerg Med 2019; 37(3): 561. doi: 10.1016/j.ajem.2018.11.027 PMID: 30470601
- Wurm S, Schreiber F, Spindelboeck W. Mefenamic acid: A possible cause of drug-induced acute pancreatitis. Pancreatology 2015; 15(5): 570-2. doi: 10.1016/j.pan.2015.08.003
- De A, Rajagopalan M, Sarda A, Das S, Biswas P. Drug reaction with eosinophilia and systemic symptoms: An update and review of recent literature. Indian J Dermatol 2018; 63(1): 30-40. doi: 10.4103/ijd.IJD_582_17 PMID: 29527023
- Blue Cross responds to IPC alert on mefenamic acid in meftal brands. Available from: https://www.thehindubusinessline.com/companies/blue-cross-responds-to-ipc-alert-on-mefenamic-acid-in-meftal-brands/article67628317.ece
补充文件
